Daniel Knecht, MD

Vice President, Health Strategy and Innovation, CVS Health
Daniel Knecht, MD

Daniel Knecht, MD is a board-certified internist currently serving as Vice President of Health Strategy and Innovation, CVS Health. In this role, he collaborates across all major CVS Health business lines to develop and execute clinical strategies that address unmet health needs. Since joining the company in 2016, Dr. Knecht has led a series of enterprise-wide strategic initiatives including the company’s efforts to combat opioid misuse and addiction. As part of the combined organization, his team focuses on leveraging data analytics and enterprise assets to provide actionable insights for patients and providers that increase value of care. 

Dr. Knecht graduated with honors from Dartmouth College and received a joint MD, MBA from Weill Cornell Medical College and Johnson Graduate School of Management where he was a recipient of the Lee Family Scholarship. He is a Fulbright Scholar in medical sciences and has performed research that explored health care deficiencies in the Negev region of Israel. Dr. Knecht is also an associate clinical professional at Mount Sinai West in New York City where he still sees patients.

Cost Management
CVS Health offers payors a new stop-loss program and installment payment plan to help mitigate the large one-time impact of costly gene therapies. These approaches are part of... More
Briefing
Data analyst sitting at computer
Care Management
There is a lot we don’t know about COVID-19 but data and data analytics can help us better predict the course of the disease, and identify best tools and solutions to help keep... More
Commentary
Patient connected with a doctor reviewing prescriptions.
Care Management
CVS Health taking steps to ensure patients and members have continued access to coronavirus-related as well as non-COVID-19 related care, collaborating to increase testing More
Commentary
Cost Management
Our new RxZERO plan design fordiabetes eliminates member out-of-pocket costs, and enables clients to help membersimprove health outcomes without raising premiums or deductibles More
White Paper
Cost Management
Gene therapies have the potential to relieve tremendous suffering for patients with genetic disorders and together we can find ways to ensure these treatments are accessible for... More
White Paper